Telemetry Investments, L.L.C. Syndax Pharmaceuticals Inc Transaction History

Telemetry Investments, L.L.C.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $136,400 - $194,800	-10,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $148,400 - $221,500	10,000 New	10,000 $174,000
Q4 2019 Feb 14, 2020	SELL	$5.43 - $9.22 $70,590 - $119,860	-13,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.47 - $10.76 $97,110 - $139,880	13,000 New	13,000 $97,000
Q2 2019 Aug 14, 2019	SELL	$4.9 - $9.31 $122,500 - $232,750	-25,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$4.26 - $6.86 $106,500 - $171,500	-25,000 Reduced 50.0%	25,000 $131,000
Q4 2018 Feb 14, 2019	BUY	$3.6 - $8.42 $97,009 - $226,893	26,947 Added 116.89%	50,000 $222,000
Q3 2018 Nov 14, 2018	SELL	$6.33 - $8.08 $164,244 - $209,651	-25,947 Reduced 52.95%	23,053 $186,000
Q2 2018 Aug 14, 2018	BUY	$6.93 - $14.63 $339,570 - $716,870	49,000 New	49,000 $344,000

202

87.1M

268K

76.8K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.03B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.